Skip to main content

Pipeline

Pre Clinical Phase 1 Phase 2 Phase 3

NuThrax™

Anthrax Vaccine Candidate
(Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant)
*Phase 3 Study: First subject enrollment targeted for 2018

NuThrax™ (Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant) is being studied for use as a third generation anthrax vaccine. This candidate consists of BioThrax® (Anthrax Vaccine Adsorbed) in combination with a novel immunostimulatory compound, CPG 7909.
 

Active Clinical Trials

  • No active clinical trials

Completed Clinical Trials

      2018*

FLU-IGIV

Seasonal Influenza Therapeutic Candidate
Hyperimmune Platform
**Phase 2 Study: First subject enrollment targeted for 2017
    2017**

UV-4B

Dengue Therapeutic Candidate
Broad Spectrum Antiviral
Phase 1b study initiated February 2017

UV-4B is an antiviral iminosugar being studied to treat dengue virus infections. In addition, future clinical activities on this compound are planned for influenza. This product candidate has a mechanism of action that inhibits a host glycosylation pathway resulting in misfolded viral glycoproteins and subsequently leading to reduced viral infectivity.

Active Clinical Trials

Completed Clinical Trials

   

ZIKV-IG

Zika Therapeutic Candidate
Hyperimmune Platform
**Phase 1 Study: First subject enrollment targeted for 2017
  2017**

GC-072

Burkholderia Therapeutic Candidate
Broad Spectrum Antibiotic

GC-072 is the lead candidate based on Emergent's EV-035 series of broad spectrum antibiotics. These compounds have a novel 4-oxoquinolizine antibacterial backbone showing activity against quinolone-resistant bacterial strains such as Burkholderia pseudomallei.

 

FILOV

Pan-filovirus Therapeutic Candidate (Ebola, Marburg, Sudan)
Hyperimmune Platform, Monoclonal Antibody
 

Clinical Trials Resources

To learn more about Clinical Trails, visit the websites below. These sites are maintained by ClinicalTrials.gov, a web-based resource that provides patients, their family members, health care professionals, researchers, and the public with easy access to information on publicly and privately supported clinical studies on a wide range of diseases and conditions. ClinicalTrials.gov is maintained by the National Library of Medicine at the National Institutes of Health.